These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 3593906)

  • 1. The effect of food on ciramadol bioavailability in normal subjects.
    Audet PR; Chiang S; Maroli A; Locniskar A; Morrison G
    Biopharm Drug Dispos; 1987; 8(3):299-304. PubMed ID: 3593906
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preliminary pharmacokinetics of intravenous ciramadol in humans.
    Rosseel MT; Bogaert MG; Oosterlinck W
    Int J Clin Pharmacol Ther Toxicol; 1984 Jun; 22(6):304-6. PubMed ID: 6547699
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The metabolic disposition of 14C-ciramadol in humans.
    Sisenwine SF; Liu AL; Tio C; Kimmel H; Freeland G
    Xenobiotica; 1986 Apr; 16(4):335-40. PubMed ID: 3754997
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of food on the pharmacokinetics and bioavailability of oral imiquimod relative to a subcutaneous dose.
    Soria I; Myhre P; Horton V; Ellefson P; McCarville S; Schmitt K; Owens M
    Int J Clin Pharmacol Ther; 2000 Oct; 38(10):476-81. PubMed ID: 11073288
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of Food Intake on the Relative Bioavailability of Amifampridine Phosphate Salt in Healthy Adults.
    Haroldsen PE; Musson DG; Hanson B; Quartel A; O'Neill CA
    Clin Ther; 2015 Jul; 37(7):1555-63. PubMed ID: 26101174
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of food on oxaprozin bioavailability.
    Chiang ST; Knowles JA; Hubsher JA; Ruelius HW; Walker BR
    J Clin Pharmacol; 1984; 24(8-9):381-5. PubMed ID: 6480879
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolic disposition of ciramadol in rhesus monkeys and rats.
    Sisenwine SF; Tio CO; Ruelius HW
    Drug Metab Dispos; 1982; 10(2):161-7. PubMed ID: 6124403
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determination of ciramadol in plasma by gas-liquid chromatography.
    Sisenwine SF; Kimmel HB; Tio CO; Liu AL; Ruelius HW
    J Pharm Sci; 1983 Jan; 72(1):85-7. PubMed ID: 6687478
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of liver disease on the disposition of ciramadol in humans.
    Hoyumpa AM; Brown MW; Johnson R; Troxell R; Snowdy P; Schenker S
    J Clin Pharmacol; 1989 Mar; 29(3):217-24. PubMed ID: 2723108
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of food and antacid on absorption of orally administered ticlopidine hydrochloride.
    Shah J; Fratis A; Ellis D; Murakami S; Teitelbaum P
    J Clin Pharmacol; 1990 Aug; 30(8):733-6. PubMed ID: 2401752
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential pharmacokinetics of diclofenac potassium for oral solution vs immediate-release tablets from a randomized trial: effect of fed and fasting conditions.
    Chen C; Bujanover S; Kareht S; Rapoport AM
    Headache; 2015 Feb; 55(2):265-75. PubMed ID: 25546369
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of food on the relative bioavailability of fadrozole hydrochloride.
    Choi RL; Sun JX; Kochak GM
    Biopharm Drug Dispos; 1993 Dec; 14(9):779-84. PubMed ID: 8298071
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determination of ciramadol and dezocine, two new analgesics, by high-performance liquid chromatography using electrochemical detection.
    Locniskar A; Greenblatt DJ
    J Chromatogr; 1986 Jan; 374(1):215-20. PubMed ID: 3753984
    [No Abstract]   [Full Text] [Related]  

  • 14. Relative bioavailability and effects of a high fat meal on single dose cilostazol pharmacokinetics.
    Bramer SL; Forbes WP
    Clin Pharmacokinet; 1999; 37 Suppl 2():13-23. PubMed ID: 10702883
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of food and tablet-dissolution characteristics on the bioavailability of linagliptin fixed-dose combination with metformin: evidence from two randomized trials.
    Metzmann K; Schnell D; Jungnik A; Ring A; Theodor R; Hohl K; Meinicke T; Friedrich C
    Int J Clin Pharmacol Ther; 2014 Jul; 52(7):549-63. PubMed ID: 24755124
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the analgesic efficacy and safety oral ciramadol, codeine, and placebo in patients with chronic cancer pain.
    Stambaugh JE; McAdams J
    J Clin Pharmacol; 1987 Feb; 27(2):162-6. PubMed ID: 3680568
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of ciramadol glucuronidation by benzodiazepines.
    Meacham RH; Sisenwine SF; Liu AL; Kick CJ; Barinov I; Ruelius HW
    Drug Metab Dispos; 1986; 14(4):430-6. PubMed ID: 2873990
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The absorption of oral micronized progesterone: the effect of food, dose proportionality, and comparison with intramuscular progesterone.
    Simon JA; Robinson DE; Andrews MC; Hildebrand JR; Rocci ML; Blake RE; Hodgen GD
    Fertil Steril; 1993 Jul; 60(1):26-33. PubMed ID: 8513955
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relative bioavailability of the fentanyl effervescent buccal tablet (FEBT) 1,080 pg versus oral transmucosal fentanyl citrate 1,600 pg and dose proportionality of FEBT 270 to 1,300 microg: a single-dose, randomized, open-label, three-period study in healthy adult volunteers.
    Darwish M; Tempero K; Kirby M; Thompson J
    Clin Ther; 2006 May; 28(5):715-24. PubMed ID: 16861093
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the Pharmacokinetics of the Phase II and Phase III Capsule Formulations of Selumetinib and the Effects of Food on Exposure: Results From Two Randomized Crossover Trials in Healthy Male Subjects.
    Tomkinson H; McBride E; Martin P; Lisbon E; Dymond AW; Cantarini M; So K; Holt D
    Clin Ther; 2017 Nov; 39(11):2260-2275.e1. PubMed ID: 28985960
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.